Immunome, Inc.IMNMNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-164.30M
↓ 360% below average
Average (6y)
$-35.73M
Historical baseline
Range
High:$-7.63M
Low:$-164.30M
CAGR
+66.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-164.30M | -1856.2% |
| 2023 | $-8.40M | +71.0% |
| 2022 | $-28.94M | -58.1% |
| 2021 | $-18.30M | -43.9% |
| 2020 | $-12.72M | -29.4% |
| 2019 | $-9.83M | -28.8% |
| 2018 | $-7.63M | - |